8-K: Tactile Medical Appoints Laura King to Board of Directors, Expanding Healthcare Expertise

Tactile Systems Technology, Inc. has appointed seasoned healthcare executive Laura King to its Board of Directors, effective January 13, 2025.

Summary

• Tactile Systems Technology, Inc. has appointed Laura G. King to its Board of Directors, effective January 13, 2025.
• Ms. King will also serve on the Audit Committee and the Compliance and Reimbursement Committee.
• The board size has been fixed at nine directors.
• Ms. King brings extensive experience from her 22-year career at General Electric Company, including roles as President and CEO of GE Healthcares Global Interventional Business.
• She has also served as CEO of BiaCure, Inc., Elucent Medical, and NeuWave Medical.
• Ms. King will receive restricted stock units (RSUs) with a pro rata value of $145,000, vesting after one year or at the 2025 annual meeting.
• She will also receive an annual cash retainer of $50,000 for board service, $10,000 for Audit Committee service, and $5,000 for Compliance and Reimbursement Committee service, all prorated for her first year.

Sentiment

Score: 8

Explanation: The appointment of a highly qualified board member is a positive development for the company, suggesting a strong commitment to governance and strategic growth.

Positives

• The appointment of Laura King brings significant healthcare leadership and experience to the board.
• Ms. King's background includes a 22-year career at General Electric Company and leadership roles in multiple healthcare companies.
• Her experience in developing innovative products and enhancing patient care aligns with Tactile Medical's mission.
• The addition of Ms. King to the Audit and Compliance & Reimbursement Committees strengthens the board's oversight capabilities.

Future Outlook

The company expects to benefit from Ms. King's experience as they continue to expand their impact in lymphedema, airway clearance, and other at-home therapies.

Management Comments

• Bill Burke, Chairman of the Board of Tactile Medical, stated, 'We are thrilled to have Laura join our Board of Directors.'
• He also noted that 'Tactile will benefit from her considerable experience leading healthcare companies that develop innovative technologies to improve patient care.'

Industry Context

This appointment reflects a trend in the medical technology industry to bring experienced healthcare executives onto boards to guide strategic growth and innovation.

Comparison to Industry Standards

• The appointment of a seasoned executive like Laura King is consistent with best practices in corporate governance for publicly traded medical technology companies.
• Her compensation package, including RSUs and cash retainers, is typical for non-employee directors in similar companies.
• Her experience at GE and other healthcare companies is comparable to board members at companies like Medtronic, Johnson & Johnson, and Stryker.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders may view the appointment of a seasoned executive positively, potentially increasing investor confidence.
• Employees may benefit from the expertise and leadership of the new board member.
• Customers may see improved products and services due to the board's strategic guidance.

Next Steps

• Ms. King will begin her service on the board and committees effective January 13, 2025.
• The initial RSU grant will be made after the close of market on the second business day following the release of the Companys financial results for the quarter ended December 31, 2024.

Key Dates

Keywords

Board of Directors, Healthcare, Medical Technology, Corporate Governance, Executive Appointment, Audit Committee, Compliance Committee, Laura King, Tactile Medical